HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gaetane Nocturne Selected Research
Gaetane Nocturne Research Topics
Disease
8
Autoimmune Diseases (Autoimmune Disease)
11/2023 - 12/2013
7
Lymphoma (Lymphomas)
10/2023 - 12/2013
6
Rheumatoid Arthritis
11/2021 - 01/2016
5
Inflammation (Inflammations)
08/2023 - 01/2019
3
B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 02/2015
2
Neoplasms (Cancer)
01/2023 - 07/2021
2
Corneal Ulcer
11/2021 - 01/2021
1
Sjogren's Syndrome (Sjogren Syndrome)
05/2024
1
Experimental Arthritis
08/2023
1
Arthritis (Polyarthritis)
08/2023
1
Keratoconjunctivitis Sicca
10/2022
1
Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2022
1
Rheumatic Fever (Acute Articular Rheumatism)
01/2022
1
Rheumatic Diseases (Rheumatism)
07/2021
1
Skin Neoplasms (Skin Cancer)
07/2021
1
Melanoma (Melanoma, Malignant)
07/2021
1
Vasculitis (Vasculitides)
03/2021
1
Atrioventricular Block
07/2020
1
Sialadenitis
01/2019
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2019
1
Connective Tissue Diseases (Connective Tissue Disease)
01/2019
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2017
1
Back Pain (Backache)
01/2015
1
Axial Spondyloarthritis
01/2015
Drug/Important Bio-Agent (IBA)
6
Tumor Necrosis Factor Inhibitors
IBA
07/2021 - 01/2017
4
Biomarkers (Surrogate Marker)
IBA
10/2022 - 01/2016
4
Rituximab (Mabthera)
FDA Link
01/2022 - 01/2019
3
Antibodies
IBA
01/2021 - 10/2018
2
Immune Checkpoint Inhibitors
IBA
05/2024 - 01/2022
2
Janus Kinase Inhibitors
IBA
01/2023 - 07/2021
2
Autoantibodies
IBA
07/2020 - 01/2019
1
Molecular Probes (Molecular Probe)
IBA
11/2023
1
Ligands
IBA
10/2023
1
Agammaglobulinaemia Tyrosine Kinase
IBA
10/2023
1
Polyethylene Glycols (Polyethylene Glycol)
FDA Link
Generic
08/2023
1
Antagomirs
IBA
08/2023
1
Liposomes (Liposome)
IBA
08/2023
1
RNA (Ribonucleic Acid)
IBA
08/2023
1
Interferons
IBA
12/2022
1
COVID-19 Vaccines
IBA
01/2022
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2022
1
tocilizumab (atlizumab)
FDA Link
11/2021
1
tofacitinib
IBA
07/2021
1
Immunosuppressive Agents (Immunosuppressants)
IBA
07/2021
1
obinutuzumab
IBA
03/2021
1
Methotrexate (Mexate)
FDA Link
Generic
01/2021
1
B-Cell Activating Factor
IBA
01/2021
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2021
1
Rheumatoid Factor
IBA
01/2021
1
Macrophage Colony-Stimulating Factor
IBA
10/2019
1
Toll-Like Receptor Agonists
IBA
01/2019
1
Bendamustine Hydrochloride
FDA Link
01/2019
1
anti-dsDNA autoantibody
IBA
01/2019
1
Adenosine (Adenocard)
FDA Link
Generic
10/2018
1
NF-kappa B (NF-kB)
IBA
04/2016
1
Antigens
IBA
02/2015
1
O,O-diisopropyl-S-benzylthiophosphate (IBP)
IBA
01/2015
1
DNA (Deoxyribonucleic Acid)
IBA
12/2013
1
Proteins (Proteins, Gene)
FDA Link
12/2013
Therapy/Procedure
4
Therapeutics
01/2022 - 06/2017
1
Biological Therapy
10/2017